Why the study?
Does bedtime dosing of candesartan reduce microalbuminuria compared to awakening dosing in hypertensives?
Does bedtime dosing of candesartan reduce microalbuminuria compared to awakening dosing in hypertensives?
Bedtime dosing of an ARB (candesartan) is superior to awakening dosing for reducing microalbuminuria in hypertensive patients, particularly those with morning hypertension.
No takes yet. Share an insight, caveat, or question.
Bedtime candesartan may be prioritized for microalbuminuria reduction in hypertension; extends chronotherapy evidence for ARBs.
Kario et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: